Donepezil 5mg + Memantine 5mg Tablets

Donepezil 5mg + Memantine 5mg combines two medicines used to manage cognitive and functional symptoms of Alzheimer's dementia. The components act on different brain-signalling systems and may be used together when combination treatment is appropriate. It does not cure dementia or restore all memory lost to the disease.
Take the tablet by mouth at the same time each day, with or without food. A caregiver can help prevent missed or repeated doses. The selected tablet must fit the person's established donepezil and memantine doses; the two components may need separate adjustment during initiation or after a treatment gap.
Donepezil reduces acetylcholine breakdown by inhibiting acetylcholinesterase. Memantine blocks excessive activation of NMDA receptors by glutamate, helping regulate signalling involved in cognition without being an acetylcholine replacement.
Nausea, diarrhoea or constipation, loss of appetite, headache, dizziness and sleep disturbance may occur. Fainting, a very slow pulse, seizures, gastrointestinal bleeding or a major change in confusion needs prompt assessment.
Tell your doctor about kidney impairment, slow heartbeat or heart block, ulcers, seizures and urinary problems. Kidney function affects memantine dosing. Amantadine, ketamine, dextromethorphan, urine-alkalinising medicines and other drugs that slow the heart can interact. Track appetite, weight, falls and functional changes during treatment.
Some people maintain better communication, attention or daily functioning with the two complementary actions. Benefit varies, and caregiver observations are important when judging whether continued combination treatment is useful.
It adds memantine, which acts on NMDA signalling rather than acetylcholine breakdown. It is not simply a higher-strength donepezil tablet.
No. Donepezil and memantine have different titration and tolerability considerations. A fixed-dose tablet may not provide the dose balance needed at every stage of treatment.
Contact the treating clinician before resuming the previous regimen. Memantine may need retitration after an interruption, and a gap of a week or more also matters for donepezil.
It is intended for a diagnosed dementia treatment plan. Occasional forgetfulness, poor sleep, depression, thyroid disease and B12 deficiency need a different assessment rather than an automatic dementia medicine.
NMDA receptor: a glutamate receptor involved in nerve signalling. Glutamate: an excitatory brain messenger. Cholinesterase inhibitor: a medicine that slows acetylcholine breakdown. Cognition: memory, attention, reasoning and related mental functions; AR: Donepezil 5mg + Memantine 5mg أقراص; FR: Donepezil 5mg + Memantine 5mg comprimés; PT: Donepezil 5mg + Memantine 5mg comprimidos; ES: Donepezil 5mg + Memantine 5mg comprimidos; RU: Donepezil 5mg + Memantine 5mg таблетки; ID: Donepezil 5mg + Memantine 5mg tablet; VI: Donepezil 5mg + Memantine 5mg viên nén; MS: Donepezil 5mg + Memantine 5mg tablet; TL: Donepezil 5mg + Memantine 5mg tableta; ZH-SG: Donepezil 5mg + Memantine 5mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Donepezil 5mg + Memantine 5mg Tablets under Neuro Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Donepezil 5mg + Memantine 5mg Tablets